SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001047469-09-007173
Filing Date
2009-08-04
Accepted
2009-08-04 13:38:39
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-4/A a2193894zs-4a.htm S-4/A 1889290
2 EXHIBIT 5.1 a2193894zex-5_1.htm EX-5.1 9595
3 EXHIBIT 8.1 a2193894zex-8_1.htm EX-8.1 15872
4 EXHIBIT 8.2 a2193894zex-8_2.htm EX-8.2 9794
5 EX-23.1 a2193480zex-23_1.htm EX-23.1 2771
6 EX-23.2 a2193480zex-23_2.htm EX-23.2 2852
7 EX-23.4 a2193480zex-23_4.htm EX-23.4 2859
8 EXHIBIT 99.5 a2193894zex-99_5.htm EX-99.5 4112
10 G156842KGI001.JPG g156842kgi001.jpg GRAPHIC 1248
11 G825671.JPG g825671.jpg GRAPHIC 12325
12 G347176.JPG g347176.jpg GRAPHIC 3908
13 filename13.htm CORRESP 366532
  Complete submission text file 0001047469-09-007173.txt   2329420
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-160257 | Film No.: 09982901
SIC: 2835 In Vitro & In Vivo Diagnostic Substances